Halozyme Therapeutics, Inc.
-
Ticker
HALO
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in San Diego, California
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
REPORT RATINGS
4.8 / 5.0 (112)
Halozyme Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 112 reviews.
Halozyme Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
View 2023 Environmental, Social & Governance Report
Older/Archived Annual Reports